Retinoic acid-induced blr1 expression requires RARα, RXR, and MAPK activation and uses ERK2 but not JNK/SAPK to accelerate cell differentiation

European Journal of Cell Biology

Volumn 80, Issue 1, 2001, Pages 59-67

  Battle, Traci E ^a,b   Roberson, Mark S ^a   Zhang, Tong ^a   Varvayanis, Susi ^a   Yen, Andrew ^a  

^a Cornell University ^*  (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

BLR1; Leukemic monocytic cell differentiation; MAPK; Retinoids

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; 6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; ADENINE; CHEMOKINE RECEPTOR; COMPLEMENTARY DNA; CYTOSINE; DNA; DNA BASE; ENZYME INHIBITOR; GUANINE; ISOPROTEIN; LIGAND; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NEOMYCIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID DERIVATIVE; RETINOID X RECEPTOR; RNA; RO 25 6603; SODIUM CHLORIDE; STEROID RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; THYMINE; THYROID HORMONE RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; BONE MARROW CELL; BURKITT LYMPHOMA; CELL ACTIVATION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN HL 60; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MYELOID LEUKEMIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0035134835     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-9335-00141     Document Type: Article

References (36)

1. Myeloid development is selectively disrupted in PU.1 null mice
2. Sequence variation of a novel heptahelical leucocyte receptor through alternative transcript formation
3. Retinoic acid-induced blr1 expression promotes ERK2 activation and cell differentiation of HL-60 cells
4. Induction of differentiation of human promyelocytic leukemia cells (HL-60) by retinoic acid
5. Myeloid differentiation and RB phosphorylation changes in HL-60 cells induced by RAR- and RXR-selective retinoic acid analogs
6. All-trans retinoic acid as a differentiation therapy in acute promyelocytic leukemias. I. Clinical results
7. Myeloid-specific gene expression
8. Characterization of a retinoic acid-responsive element isolated by whole genome PCR
9. Identification of a retinoic acid-responsive element in the retinoic acid receptor β gene
10. Differentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphoma
11. A synthetic inhibitor of the mitogen-activated protein kinase cascade
12. Retinoic acid response element in the human alcohol dehydrogenase gene ADH3: Implication for regulation of retinoic acid synthesis
13. Alltrans-and 9-cis-retinoic acid induction of CRABP II transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs
14. Transmembrane topology of the lymphocyte-specific G-protein-coupled receptor BLR1: Analysis by flow cytometry and immunocytochemistry
15. Expression of the G protein-coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells
16. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen
17. Selective expression of the murine homologue of the G protein-coupled receptor BLR1 in B cell differentiation, B cell neoplasia and defined areas of the cerebellum
18. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1
19. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
20. The G protein-coupled receptor BLR1 is involved in murine B cell differentiation and is also expressed in neuronal tissues
21. Identification of a retinoic acid-responsive enhancer 3′ of the murine homeobox gene Hox-1.6
22. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5
23. Multiple isoforms of the mouse retinoic acid receptor α are generated by alternative splicing and differential induction by retinoic acid
24. Mouse retinoic acid receptor α2 isoform is transcribed from a promoter that contains a retinoic acid response element
25. The retinoid receptors
26. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR
27. Selective synthetic ligands for human nuclear retinoic acid receptors
28. Mapping of a retinoic acid-responsive element in the promoter region of the complement factor H gene
29. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors
30. A retinoic acid-responsive element in the apolipoprotein AI gene distinguishes between two different retinoic acid response pathways
31. Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene
32. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid)
33. Downsstream activation of a TATA-less promoter by Oct-2, Bob1, and NF-κB directs expression of the homing receptor BLR1 to mature B cells
34. Retinoic acid selectively activates the ERK2 but not the JNK/SAPK or P38 kinases when inducing myeloid differentiation
35. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest
36. Function of PU.1 (Spi-1), C/EBP, ans AML1 in early myelopoiesis regulation of multiple myeloid CSF receptor promoters